{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:14:02Z","timestamp":1782792842190,"version":"3.54.5"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["726318"],"award-info":[{"award-number":["726318"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/19\/84\/34771"],"award-info":[{"award-number":["PG\/19\/84\/34771"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/21\/10541"],"award-info":[{"award-number":["PG\/21\/10541"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/21\/10634"],"award-info":[{"award-number":["PG\/21\/10634"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000860","name":"European Society of Cardiology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000860","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2017NKB2N4_003"],"award-info":[{"award-number":["2017NKB2N4_003"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.phrs.2021.106053","type":"journal-article","created":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T10:48:31Z","timestamp":1640947711000},"page":"106053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Systemic administration of glucocorticoids, cardiovascular complications and mortality in patients hospitalised with COVID-19, SARS, MERS or influenza: A systematic review and meta-analysis of randomised trials"],"prefix":"10.1016","volume":"176","author":[{"given":"Elisabetta","family":"Caiazzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma O.M.","family":"Rezig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Bruzzese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Ialenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Cicala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.F.","family":"Cleland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz J.","family":"Guzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Maffia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierpaolo","family":"Pellicori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.phrs.2021.106053_bib1","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1371\/journal.pmed.0030343","article-title":"SARS: systematic review of treatment effects","volume":"3","author":"Stockman","year":"2006","journal-title":"PLoS Med."},{"issue":"6","key":"10.1016\/j.phrs.2021.106053_bib2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1164\/rccm.201706-1172OC","article-title":"Corticosteroid therapy for critically ill patients with middle east respiratory syndrome","volume":"197","author":"Arabi","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.phrs.2021.106053_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032280","article-title":"Systemic corticosteroids and early administration of antiviral agents for pneumonia with acute wheezing due to influenza A(H1N1)pdm09 in Japan","volume":"7","author":"Kudo","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.phrs.2021.106053_bib4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"RECOVERY Collaborative","year":"2021","journal-title":"New Engl. J. Med."},{"issue":"13","key":"10.1016\/j.phrs.2021.106053_bib5","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2020.17023","article-title":"Association between administration of systemic corticosteroids and mortality among critically ill patients with covid-19: a meta-analysis","volume":"324","author":"WHO Rapid Evidence Appraisal for COVID- Therapies (REACT) Working","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2021.106053_bib6","article-title":"COVID-19 and its cardiovascular effects: a systematic review of prevalence studies","volume":"3","author":"Pellicori","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10296","key":"10.1016\/j.phrs.2021.106053_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0140-6736(21)00799-6","article-title":"Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study","volume":"398","author":"Drake","year":"2021","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.phrs.2021.106053_bib8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41569-020-0413-9","article-title":"COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives","volume":"17","author":"Nishiga","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"8","key":"10.1016\/j.phrs.2021.106053_bib9","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/hrt.2003.020180","article-title":"Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study","volume":"90","author":"Souverein","year":"2004","journal-title":"Heart"},{"issue":"10","key":"10.1016\/j.phrs.2021.106053_bib10","doi-asserted-by":"crossref","first-page":"764","DOI":"10.7326\/0003-4819-141-10-200411160-00007","article-title":"Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease","volume":"141","author":"Wei","year":"2004","journal-title":"Ann. Intern. Med."},{"issue":"12","key":"10.1016\/j.phrs.2021.106053_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003432","article-title":"Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: a population-based cohort study","volume":"17","author":"Pujades-Rodriguez","year":"2020","journal-title":"PLoS Med."},{"issue":"12","key":"10.1016\/j.phrs.2021.106053_bib12","doi-asserted-by":"crossref","first-page":"E295","DOI":"10.1503\/cmaj.191012","article-title":"Oral glucocorticoids and incidence of hypertension in people with chronic inflammatory diseases: a population-based cohort study","volume":"192","author":"Mebrahtu","year":"2020","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.phrs.2021.106053_bib13","unstructured":"G. Schwarzer, meta: An R package formeta-analysis. R news. 2007;7(3):40-45."},{"issue":"9977","key":"10.1016\/j.phrs.2021.106053_bib14","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(14)62447-8","article-title":"Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"385","author":"Blum","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.phrs.2021.106053_bib15","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1183\/13993003.00474-2016","article-title":"Pathogen- and antibiotic-specific effects of prednisone in community-acquired pneumonia","volume":"48","author":"Wirz","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.phrs.2021.106053_bib16","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jcv.2004.07.006","article-title":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients","volume":"31","author":"Lee","year":"2004","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.phrs.2021.106053_bib17","first-page":"1","article-title":"Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial","volume":"21","author":"Ranjbar","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.phrs.2021.106053_bib18","unstructured":"M.W. Munch, S.N.Myatra, B.K. Tirupakuzhi Vijayaraghavan, et al., Dexamethasone 12 mg versus6 mg for patients with COVID-19 and severe hypoxia: an international,randomized, blinded trial. medRxiv. 2021:2021.2007.2022.21260755."},{"issue":"13","key":"10.1016\/j.phrs.2021.106053_bib19","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.2020.17022","article-title":"Effect of Hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial","volume":"324","author":"Angus","year":"2020","journal-title":"JAMA"},{"issue":"7\u20138","key":"10.1016\/j.phrs.2021.106053_bib20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00508-020-01805-8","article-title":"Methylprednisolone in adults hospitalized with COVID-19 pneumonia: an open-label randomized trial (GLUCOCOVID)","volume":"133","author":"Corral-Gudino","year":"2021","journal-title":"Wien. Klin. Wochenschr."},{"issue":"13","key":"10.1016\/j.phrs.2021.106053_bib21","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1001\/jama.2020.16761","article-title":"Effect of hydrocortisone on 21-day mortality or respiratory support among critically ill patients with COVID-19: a randomized clinical trial","volume":"324","author":"Dequin","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2021.106053_bib22","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1183\/13993003.02808-2020","article-title":"Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial","volume":"56","author":"Edalatifard","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"10","key":"10.1016\/j.phrs.2021.106053_bib23","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/aas.13941","article-title":"Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia: the COVID STEROID randomised, placebo-controlled trial","volume":"65","author":"Munch","year":"2021","journal-title":"Acta Anaesthesiol. Scand."},{"issue":"2","key":"10.1016\/j.phrs.2021.106053_bib24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000512063","article-title":"Early use of corticosteroid may prolong SARS-CoV-2 shedding in non-intensive care unit patients with COVID-19 pneumonia: a multicenter, single-blind, randomized control trial","volume":"100","author":"Tang","year":"2021","journal-title":"Respiration"},{"issue":"13","key":"10.1016\/j.phrs.2021.106053_bib25","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.2020.17021","article-title":"Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial","volume":"324","author":"Tomazini","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2021.106053_bib26","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.ejphar.2021.173947","article-title":"No clinical benefit of high dose corticosteroid administration in patients with COVID-19: a preliminary report of a randomized clinical trial","volume":"897","author":"Jamaati","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.phrs.2021.106053_bib27","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1093\/cid\/ciaa1177","article-title":"Methylprednisolone as adjunctive therapy for patients hospitalized with coronavirus disease 2019 (COVID-19; Metcovid): a randomized, double-blind, phase IIb, placebo-controlled trial","volume":"72","author":"Jeronimo","year":"2021","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2021.106053_bib28","doi-asserted-by":"crossref","first-page":"8816","DOI":"10.1038\/s41598-021-88086-x","article-title":"Short term survival of critically ill COVID-19 Egyptian patients on assisted ventilation treated by either Dexamethasone or Tocilizumab","volume":"11","author":"Rashad","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.phrs.2021.106053_bib29","article-title":"Corticosteroids as adjunctive therapy in the treatment of influenza","volume":"2","author":"Lansbury","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.phrs.2021.106053_bib30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13054-019-2395-8","article-title":"The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis","volume":"23","author":"Ni","year":"2019","journal-title":"Crit. Care"},{"issue":"2","key":"10.1016\/j.phrs.2021.106053_bib31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/infdis\/jiu645","article-title":"Effect of corticosteroid therapy on influenza-related mortality: a systematic review and meta-analysis","volume":"212","author":"Rodrigo","year":"2015","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2021.106053_bib32","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1038\/s41598-020-59732-7","article-title":"Use of corticosteroids in influenza-associated acute respiratory distress syndrome and severe pneumonia: a systemic review and meta-analysis","volume":"10","author":"Zhou","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.phrs.2021.106053_bib33","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/s41375-020-0848-3","article-title":"Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis","volume":"34","author":"Li","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.phrs.2021.106053_bib34","article-title":"Corticosteroids as adjunctive therapy in the treatment of influenza","volume":"3","author":"Rodrigo","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10223","key":"10.1016\/j.phrs.2021.106053_bib35","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","volume":"395","author":"Russell","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.phrs.2021.106053_bib36","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1164\/rccm.202008-3265OC","article-title":"Tissue-specific immunopathology in fatal COVID-19","volume":"203","author":"Dorward","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.phrs.2021.106053_bib37","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.chest.2020.10.054","article-title":"Impact of corticosteroids in coronavirus disease 2019 outcomes: systematic review and meta-analysis","volume":"159","author":"Cano","year":"2021","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.phrs.2021.106053_bib38","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00134-021-06394-2","article-title":"Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis","volume":"47","author":"Chaudhuri","year":"2021","journal-title":"Intensive Care Med."},{"issue":"8","key":"10.1016\/j.phrs.2021.106053_bib39","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1080\/17476348.2021.1925546","article-title":"Does methylprednisolone reduce the mortality risk in hospitalized COVID-19 patients? A meta-analysis of randomized control trials","volume":"15","author":"Hasan","year":"2021","journal-title":"Expert Rev. Respir. Med."},{"issue":"2","key":"10.1016\/j.phrs.2021.106053_bib40","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/SHK.0000000000001738","article-title":"Comparison of associations between glucocorticoids treatment and mortality in COVID-19 patients and sars patients: a systematic review and meta-analysis","volume":"56","author":"Li","year":"2021","journal-title":"Shock"},{"issue":"10","key":"10.1016\/j.phrs.2021.106053_bib41","doi-asserted-by":"crossref","first-page":"627","DOI":"10.21037\/atm-20-3307","article-title":"Effectiveness and safety of glucocorticoids to treat COVID-19: a rapid review and meta-analysis","volume":"8","author":"Lu","year":"2020","journal-title":"Ann. Transl. Med."},{"issue":"1","key":"10.1016\/j.phrs.2021.106053_bib42","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41392-021-00521-7","article-title":"Efficacy and safety of systematic corticosteroids among severe COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials","volume":"6","author":"Ma","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.phrs.2021.106053_bib43","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1053\/j.jvca.2020.11.057","article-title":"Corticosteroids for patients with coronavirus disease 2019 (COVID-19) with different disease severity: a meta-analysis of randomized clinical trials","volume":"35","author":"Pasin","year":"2021","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"issue":"20","key":"10.1016\/j.phrs.2021.106053_bib44","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000025719","article-title":"Corticosteroid therapy for COVID-19 A systematic review and meta-analysis of randomized controlled trials","volume":"100","author":"Pulakurthi","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.phrs.2021.106053_bib45","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6650469","article-title":"Severity and mortality associated with steroid use among patients with COVID-19: a systematic review and meta-analysis","volume":"2021","author":"Sahilu","year":"2021","journal-title":"Interdiscip. Perspect. Infect. Dis."},{"issue":"3","key":"10.1016\/j.phrs.2021.106053_bib46","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/jmv.26483","article-title":"Are the steroids a blanket solution for COVID-19? A systematic review and meta-analysis","volume":"93","author":"Sarkar","year":"2021","journal-title":"J. Med. Virol."},{"issue":"6","key":"10.1016\/j.phrs.2021.106053_bib47","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4103\/ijp.ijp_1146_20","article-title":"Efficacy and safety of steroid therapy in COVID-19: a rapid systematic review and meta-analysis","volume":"52","author":"Sarma","year":"2020","journal-title":"Indian J. Pharmacol."},{"issue":"11","key":"10.1016\/j.phrs.2021.106053_bib48","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.jiph.2020.09.008","article-title":"Association of corticosteroids use and outcomes in COVID-19 patients: a systematic review and meta-analysis","volume":"13","author":"Tlayjeh","year":"2020","journal-title":"J. Infect. Public Health"},{"issue":"1","key":"10.1016\/j.phrs.2021.106053_bib49","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1186\/s13054-020-03400-9","article-title":"Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes","volume":"24","author":"van Paassen","year":"2020","journal-title":"Crit. Care"},{"issue":"4","key":"10.1016\/j.phrs.2021.106053_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249481","article-title":"The proportion and effect of corticosteroid therapy in patients with COVID-19 infection: a systematic review and meta-analysis","volume":"16","author":"Wang","year":"2021","journal-title":"PLoS One"},{"issue":"27","key":"10.1016\/j.phrs.2021.106053_bib51","doi-asserted-by":"crossref","first-page":"E755","DOI":"10.1503\/cmaj.200645","article-title":"Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis","volume":"192","author":"Ye","year":"2020","journal-title":"CMAJ"},{"issue":"8","key":"10.1016\/j.phrs.2021.106053_bib52","first-page":"1411","article-title":"Corticosteroids on the management of coronavirus disease 2019 (COVID-19): a systemic review and meta-analysis","volume":"49","author":"Yousefifard","year":"2020","journal-title":"Iran. J. Public Health"},{"key":"10.1016\/j.phrs.2021.106053_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40121-021-00518-3","article-title":"Efficacy and safety of corticosteroid use in coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis","volume":"10","author":"Cui","year":"2021","journal-title":"Infect. Dis. Ther."},{"issue":"4","key":"10.1016\/j.phrs.2021.106053_bib54","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/jrsm.1356","article-title":"A new justification of the Hartung-Knapp method for random-effects meta-analysis based on weighted least squares regression","volume":"10","author":"van Aert","year":"2019","journal-title":"Res. Synth. Methods"},{"issue":"1","key":"10.1016\/j.phrs.2021.106053_bib55","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2344\/0003-3006-60.1.25","article-title":"Basic and clinical pharmacology of glucocorticosteroids","volume":"60","author":"Becker","year":"2013","journal-title":"Anesth. Prog."},{"issue":"10303","key":"10.1016\/j.phrs.2021.106053_bib56","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(21)01744-X","article-title":"Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial","volume":"398","author":"Yu","year":"2021","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.phrs.2021.106053_bib57","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S2213-2600(21)00160-0","article-title":"Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial","volume":"9","author":"Ramakrishnan","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.phrs.2021.106053_bib58","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1186\/s13063-020-04643-1","article-title":"Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial","volume":"21","author":"Villar","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.phrs.2021.106053_bib59","article-title":"Effect of 12 mg vs 6 mg of dexamethasone on the number of days alive without life support in adults with COVID-19 and severe hypoxemia: the COVID STEROID 2 randomized trial","author":"Group","year":"2021","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.phrs.2021.106053_bib60","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J. Clin. Epidemiol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366182100637X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366182100637X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:26:39Z","timestamp":1760912799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104366182100637X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":60,"alternative-id":["S104366182100637X"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2021.106053","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic administration of glucocorticoids, cardiovascular complications and mortality in patients hospitalised with COVID-19, SARS, MERS or influenza: A systematic review and meta-analysis of randomised trials","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2021.106053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106053"}}